Please note: The University of Texas Health Science Center at San Antonio will now be called "UT Health San Antonio."

Filter By Categories

Filter by Program Categories

CEO of Rapamycin Holdings Dr. Randy Goldsmith To Speak At San Antonio Postdoctoral Research Forum

← Previous entry Next entry →


Author: GSBS | Category: Opportunities | August 17, 2016

The UTHSCSA Postdoctoral (UP) Association will host the 4th Annual San Antonio Postdoctoral Research Forum on Wednesday, September 21, 2016 at 11 a.m. to 5 p.m. at Holly Auditorium.

The forum provides an opportunity to showcase research by postdocs at the Texas Biomedical Research Institute, U.S. Army Institute of Surgical Research, The University of Texas Health Science Center at San Antonio, and The University of Texas at San Antonio. 

This year's speaker is Dr. Randy Goldsmith, CEO of Rapamycin Holdings. Dr. Goldsmith has practiced in the field of innovation-led economic development since 1988, and has directly assisted more than 1000 entrepreneurs in their efforts to launch new companies. He has also participated in the creation and management of five investment funds totaling $20 million for startup ventures.

He is a frequent presenter at national and international events focused on technology commercialization and new ventures. He was president of the San Antonio Technology Accelerator Initiative or SATAI — renamed Startech in San Antonio from 2002 until 2006. Randy is a founding member of the Capital Formation Institute, the Texas Coalition for Capital, the Defense Transformation Institute, and the Venture Coaching Academy.

Randy recently published The Guardian Angel: Every Entrepreneur Needs One, a fictional narrative directed toward entrepreneurs starting new ventures.

Abstracts are due Aug 22.

For more information contact UP via email: UP@uthscsa.edu



Copyright © 2017 The University of Texas Health Science Center at San Antonio

Links provided from the UTHSCSA pages to other websites do not constitute or imply an endorsement of those sites, their content, or products and services associated with those sites.

← Previous entry Next entry →


comments powered by Disqus